DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy) (DOSTILCU)

April 11, 2022 updated by: Aesculap AG

Prospective, Monocentric, Single Arm, Observational PMCF - Study on the Performance and Safety of Double-Shank Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy)

Prospective, monocentric, single arm, observational PMCF - Study on the Performance and Safety of Double-Shank Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy)

Study Overview

Detailed Description

The objective of this observational study is to collect systematically and proactively data regarding the Aesculap® DS Titanium Ligation Clip under daily clinical practice when used in urology in different indications.

The hypothesis of this study is that this event, slippage / movement of the clip, is extremely rare through the design if used in accordance with the Instructions for Use (IfU). The observed rate through the total number of clips might be a valuable parameter and could influence future research.

Furthermore, this study is one of the PMCF measures which enable the manufacturer to monitor the safety and performance of the Aesculap® DS Titanium Ligation Clips. The products bear the CE-marking and are routinely used within this institution for the above-mentioned procedures.

Study Type

Observational

Enrollment (Actual)

67

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Offenburg, Germany, 77654
        • Ortenau Klinikum Klinik für Urologie und Kinderurologie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Data is collected preoperatively, intraoperatively and until discharge of all consecutive patients fulfilling the inclusion and exclusion criteria in a single site.

Description

Inclusion: Inclusion Criteria:

  • Planned Da Vinci radical prostatectomy using DS Titanium Ligation Clips (according to the IfU) - OR
  • Planned laparoscopic nephrectomy using Titanium Ligation Clip (according to the IfU) - OR
  • Planned Da Vinci partial nephrectomy using Titanium Ligation Clip (according to the IfU)
  • Patient's written informed consent
  • Age ≥ 18 years
  • Intraoperative Usage of DS Titanium Ligation Clips (according to the IfU)

Exclusion: Exclusion Criteria:

• None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of slippage / movement of the clip in relationship to the total number of used clips.
Time Frame: Intraoperatively

Slippage / movement of the Aesculap® DS Titanium Ligation Clip is an observable slippage, movement, or rotation after the clip was successfully applied and the application forceps was removed. The number of observed slippage / movement of the clip will be documented on the CRF, the clip size, step of the procedure and further measures were necessary, i.e. removal of the clip or application of another clip, will be documented.

In the end the rate will be brought in relationship to the overall number of applied clips. Thus, the number of applied clips is documented, for each clip size.

Intraoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of Adverse events (intra- and postoperative)
Time Frame: up to discharge from hospital (approximately 10 days post surgery)
  • Postoperative bleedings
  • Infections
  • Urine extravasation in partial nephrectomy
  • Prolonged urinary catheter drainage in radical prostatectomies
  • Ileus
  • Venous thrombo-embolic events
  • Sepsis
  • Other
up to discharge from hospital (approximately 10 days post surgery)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
intraoperative blood loss
Time Frame: intraoperatively
Estimated intraoperative blood loss
intraoperatively
Total operative time
Time Frame: intraoperatively
Estimated operative time from first cut to last stitch
intraoperatively
Length of hospital stay
Time Frame: up to discharge from hospital (approximately 10 days post surgery)
Length of patient's stay in hospital after surgery
up to discharge from hospital (approximately 10 days post surgery)
Handling parameters
Time Frame: intraoperatively
The handling performance of the clip is assessed on a five point likert scale (very good, good, acceptable, poor) in four different handling aspects
intraoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Jörg Simon, PD Dr. med., Ortenau KlinikumKlinik für Urologie und Kinderurologie ChefarztEbertplatz 1277654 Offenburg

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 27, 2021

Primary Completion (ACTUAL)

January 26, 2022

Study Completion (ACTUAL)

January 29, 2022

Study Registration Dates

First Submitted

April 27, 2021

First Submitted That Met QC Criteria

April 30, 2021

First Posted (ACTUAL)

May 3, 2021

Study Record Updates

Last Update Posted (ACTUAL)

April 12, 2022

Last Update Submitted That Met QC Criteria

April 11, 2022

Last Verified

April 1, 2022

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Kidney Cancer

Subscribe